SELLAS has announced positive data from preclinical studies identifying the ASXL1 mutation as a predictor of response to ...
As the first cohort of patients are dosed in the Phase II trial, multiple new trial sites are added for the glioblastoma ...
Sequana Medical’s other lead candidate is alfapump, a device for patients with a buildup of fluid in the abdomen. Image credit: Shutterstock / Sadovnikova Olga. Following positive data reported ...
Conducted across 88 sites in seven countries, the trial included subjects from a diverse demographic. Credit: New Africa/Shutterstock. Gilead Sciences has announced the outcomes from the randomised ...
Asthma and COPD affect millions of patients worldwide. Credit: Andrew Angelov / Shutterstock. A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic ...